Variants of the xeroderma pigmentosum variant gene (POLH) are associated with melanoma risk

European Journal of Cancer

Volumn 45, Issue 18, 2009, Pages 3228-3236

  Di Lucca, Julie ^a   Guedj, Mickael ^b,i   Lacapère, Jean Jacques ^c   Fargnoli, Maria Concetta ^d   Bourillon, Agnes ^a   Dieudé, Philippe ^a   Dupin, Nicolas ^e   Wolkenstein, Pierre ^f   Aegerter, Philippe ^g   Saiag, Philippe ^g   Descamps, Vincent ^a   Lebbe, Celeste ^h   Basset Seguin, Nicole ^h   Peris, Ketty ^d   Grandchamp, Bernard ^a   Soufir, Nadem ^a  

^a BICHAT HOSPITAL   (France)

^b Programme CIT   (France)

^c CENTRE DE RECHERCHE BIOMÉDICALE BICHAT BEAUJON CRB3   (France)

^d UNIVERSITY OF L'AQUILA   (Italy)

^e Paris Descartes University   (France)

^f HENRI MONDOR HOSPITAL   (France)

^g HÔPITAL AMBROISE PARÉ   (France)

^h SAINT LOUIS HOSPITAL   (France)

ⁱ University of Paris 5   (France)

Author keywords

DNA repair; Melanoma genetics; POLH; Polymorphism; Xeroderma pigmentosum

Indexed keywords

DNA POLYMERASE;

ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DNA SYNTHESIS; FAMILY HISTORY; FRANCE; GENE; GENE FREQUENCY; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; HIGH RISK POPULATION; HUMAN; ITALY; MAJOR CLINICAL STUDY; MELANOMA; NUCLEOTIDE SEQUENCE; PENETRANCE; POLH GENE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SKIN CARCINOMA; XERODERMA PIGMENTOSUM;

EID: 70450231742     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.04.034     Document Type: Article

References (49)

1. de Vries E., Bray F.I., Coebergh J.W., and Parkin D.M. Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia. Int J Cancer 107 1 (2003) 119-126
2. Katalinic A., Kunze U., and Schafer T. Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer). Brit J Dermatol 149 6 (2003) 1200-1206
3. StatBite: Distribution of melanoma incidence and mortality by age, 2001-2005. J Natl Cancer Inst 2008;100(21):1498.
4. Hussussian C.J., Struewing J.P., Goldstein A.M., Higgins P.A., Ally D.S., Sheahan M.D., et al. Germline p16 mutations in familial melanoma. Nat Genet 8 1 (1994) 15-21
5. Kamb A., Gruis N.A., Weaver-Feldhaus J., Liu Q., Harshman K., Tavtigian S.V., et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science 264 5157 (1994) 436-440
6. Zuo L., Weger J., Yang Q., Goldstein A.M., Tucker M.A., Walker G.J., et al. Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma. Nat Genet 12 1 (1996) 97-99
7. Monzon J., Liu L., Brill H., Goldstein A.M., Tucker M.A., From L., et al. CDKN2A mutations in multiple primary melanomas. New Engl J Med 338 13 (1998) 879-887
8. Fernandez L.P., Milne R.L., Pita G., Aviles J.A., Lazaro P., Benitez J., et al. SLC45A2: a novel malignant melanoma-associated gene. Human Mutat 29 9 (2008) 1161-1167
9. Guedj M., Bourillon A., Combadieres C., Rodero M., Dieude P., Descamps V., et al. Variants of the MATP/SLC45A2 gene are protective for melanoma in the French population. Human Mutat 29 9 (2008) 1154-1160
10. Palmer J.S., Duffy D.L., Box N.F., Aitken J.F., O'Gorman L.E., Green A.C., et al. Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype?. Am J Human Genet 66 1 (2000) 176-186
11. Gudbjartsson D.F., Sulem P., Stacey S.N., Goldstein A.M., Rafnar T., Sigurgeirsson B., et al. ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma. Nat Genet 40 7 (2008) 886-891
12. Sturm R.A., Duffy D.L., Box N.F., Chen W., Smit D.J., Brown D.L., et al. The role of melanocortin-1 receptor polymorphism in skin cancer risk phenotypes. Pigment Cell Res 16 3 (2003) 266-272
13. Fargnoli M.C., Argenziano G., Zalaudek I., and Peris K. High- and low-penetrance cutaneous melanoma susceptibility genes. Exp Rev Anticancer Ther 6 5 (2006) 657-670
14. Graf J., Hodgson R., and van Daal A. Single nucleotide polymorphisms in the MATP gene are associated with normal human pigmentation variation. Human Mutat 25 3 (2005) 278-284
15. Sulem P., Gudbjartsson D.F., Stacey S.N., Helgason A., Rafnar T., Jakobsdottir M., et al. Two newly identified genetic determinants of pigmentation in Europeans. Nat Genet 40 7 (2008) 835-837
16. Sulem P., Gudbjartsson D.F., Stacey S.N., Helgason A., Rafnar T., Magnusson K.P., et al. Genetic determinants of hair, eye and skin pigmentation in Europeans. Nat Genet 39 12 (2007) 1443-1452
17. Brown K.M., Macgregor S., Montgomery G.W., Craig D.W., Zhao Z.Z., Iyadurai K., et al. Common sequence variants on 20q11 22 confer melanoma susceptibility. Nat Genet 40 7 (2008) 838-840
18. Stary A., and Sarasin A. The genetics of the hereditary xeroderma pigmentosum syndrome. Biochimie 84 1 (2002) 49-60
19. Wei Q., Lee J.E., Gershenwald J.E., Ross M.I., Mansfield P.F., Strom S.S., et al. Repair of UV light-induced DNA damage and risk of cutaneous malignant melanoma. J Natl Cancer Inst 95 4 (2003) 308-315
20. Winsey S.L., Haldar N.A., Marsh H.P., Bunce M., Marshall S.E., Harris A.L., et al. A variant within the DNA repair gene XRCC3 is associated with the development of melanoma skin cancer. Cancer Res 60 20 (2000) 5612-5616
21. Povey J.E., Darakhshan F., Robertson K., Bisset Y., Mekky M., Rees J., et al. DNA repair gene polymorphisms and genetic predisposition to cutaneous melanoma. Carcinogenesis 28 5 (2007) 1087-1093
22. Baccarelli A., Calista D., Minghetti P., Marinelli B., Albetti B., Tseng T., et al. XPD gene polymorphism and host characteristics in the association with cutaneous malignant melanoma risk. Brit J Cancer 90 2 (2004) 497-502
23. Blankenburg S., Konig I.R., Moessner R., Laspe P., Thoms K.M., Krueger U., et al. No association between three xeroderma pigmentosum group C and one group G gene polymorphisms and risk of cutaneous melanoma. Eur J Human Genet 13 2 (2005) 253-255
24. Debniak T., Scott R.J., Huzarski T., Byrski T., Masojc B., van de Wetering T., et al. XPD common variants and their association with melanoma and breast cancer risk. Breast Cancer Res Treat 98 2 (2006) 209-215
25. Kertat K., Rosdahl I., Sun X.F., Synnerstad I., and Zhang H. The Gln/Gln genotype of XPD codon 751 as a genetic marker for melanoma risk and Lys/Gln as an important predictor for melanoma progression: a case control study in the Swedish population. Oncol Rep 20 1 (2008) 179-183
26. Duan Z., Shen H., Lee J.E., Gershenwald J.E., Ross M.I., Mansfield P.F., et al. DNA repair gene XRCC3 241Met variant is not associated with risk of cutaneous malignant melanoma. Cancer Epidemiol Biomark Prev 11 10 Pt 1 (2002) 1142-1143
27. Han J., Colditz G.A., Samson L.D., and Hunter D.J. Polymorphisms in DNA double-strand break repair genes and skin cancer risk. Cancer Res 64 9 (2004) 3009-3013
28. Han J., Colditz G.A., Liu J.S., and Hunter D.J. Genetic variation in XPD, sun exposure, and risk of skin cancer. Cancer Epidemiol Biomark Prev 14 6 (2005) 1539-1544
29. Li C., Hu Z., Liu Z., Wang L.E., Strom S.S., Gershenwald J.E., et al. Polymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of cutaneous melanoma: a case-control analysis. Cancer Epidemiol Biomark Prev 15 12 (2006) 2526-2532
30. Tomescu D., Kavanagh G., Ha T., Campbell H., and Melton D.W. Nucleotide excision repair gene XPD polymorphisms and genetic predisposition to melanoma. Carcinogenesis 22 3 (2001) 403-408
31. Blankenburg S., Konig I.R., Moessner R., Laspe P., Thoms K.M., Krueger U., et al. Assessment of 3 xeroderma pigmentosum group C gene polymorphisms and risk of cutaneous melanoma: a case-control study. Carcinogenesis 26 6 (2005) 1085-1090
32. Masutani C., Kusumoto R., Yamada A., Dohmae N., Yokoi M., Yuasa M., et al. The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase eta. Nature 399 6737 (1999) 700-704
33. Itoh T., Linn S., Kamide R., Tokushige H., Katori N., Hosaka Y., et al. Xeroderma pigmentosum variant heterozygotes show reduced levels of recovery of replicative DNA synthesis in the presence of caffeine after ultraviolet irradiation. J Invest Dermatol 115 6 (2000) 981-985
34. Johnson R.E., Kondratick C.M., Prakash S., and Prakash L. HRAD30 mutations in the variant form of xeroderma pigmentosum. Science 285 5425 (1999) 263-265
35. Yuasa M., Masutani C., Eki T., and Hanaoka F. Genomic structure, chromosomal localization and identification of mutations in the xeroderma pigmentosum variant (XPV) gene. Oncogene 19 41 (2000) 4721-4728
36. Broughton B.C., Cordonnier A., Kleijer W.J., Jaspers N.G., Fawcett H., Raams A., et al. Molecular analysis of mutations in DNA polymerase eta in xeroderma pigmentosum-variant patients. Proc Natl Acad Sci USA 99 2 (2002) 815-820
37. Gratchev A., Strein P., Utikal J., and Sergij G. Molecular genetics of xeroderma pigmentosum variant. Exp Dermatol 12 5 (2003) 529-536
38. Tanioka M., Masaki T., Ono R., Nagano T., Otoshi-Honda E., Matsumura Y., et al. Molecular analysis of DNA polymerase eta gene in Japanese patients diagnosed as xeroderma pigmentosum variant type. J Invest Dermatol 127 7 (2007) 1745-1751
39. Inui H., Oh K.S., Nadem C., Ueda T., Khan S.G., Metin A., et al. Xeroderma pigmentosum-variant patients from America, Europe, and Asia. J Invest Dermatol 128 8 (2008) 2055-2068
40. Cleaver J.E. Common pathways for ultraviolet skin carcinogenesis in the repair and replication defective groups of xeroderma pigmentosum. J Dermatol Sci 23 1 (2000) 1-11
41. Kannouche P., Broughton B.C., Volker M., Hanaoka F., Mullenders L.H., and Lehmann A.R. Domain structure, localization, and function of DNA polymerase eta, defective in xeroderma pigmentosum variant cells. Genes Dev 15 2 (2001) 158-172
42. Ohkumo T., Kondo Y., Yokoi M., Tsukamoto T., Yamada A., Sugimoto T., et al. UV-B radiation induces epithelial tumors in mice lacking DNA polymerase eta and mesenchymal tumors in mice deficient for DNA polymerase iota. Mol Cell Biol 26 20 (2006) 7696-7706
43. Dieude P., Teixeira V.H., Pierlot C., Cornelis F., and Petit-Teixeira E. Testing for linkage and association with rheumatoid arthritis a ptpn22 promoter polymorphism reported to be associated and linked with type 1 diabetes in the Caucasian population. Ann Rheum Dis 67 6 (2008) 900-901
44. Bomar M.G., Pai M.T., Tzeng S.R., Li S.S., and Zhou P. Structure of the ubiquitin-binding zinc finger domain of human DNA Y-polymerase eta. EMBO Rep 8 3 (2007) 247-251
45. Alt A., Lammens K., Chiocchini C., Lammens A., Pieck J.C., Kuch D., et al. Bypass of DNA lesions generated during anticancer treatment with cisplatin by DNA polymerase eta. Science 318 5852 (2007) 967-970
46. Trincao J., Johnson R.E., Escalante C.R., Prakash S., Prakash L., Aggarwal A.K., et al. Structure of the catalytic core of S. cerevisiae DNA polymerase eta: implications for translesion DNA synthesis. Mol Cell 8 2 (2001) 417-426
47. Dieude P., Guedj M., Wipff J., Avouac J., Hachulla E., Diot E., et al. The PTPN22 620W allele confers susceptibility to systemic sclerosis: findings of a large case-control study of European Caucasians and a meta-analysis. Arthritis Rheum 58 7 (2008) 2183-2188
48. Lin Q., Clark A.B., McCulloch S.D., Yuan T., Bronson R.T., Kunkel T.A., et al. Increased susceptibility to UV-induced skin carcinogenesis in polymerase eta-deficient mice. Cancer Res 66 1 (2006) 87-94
49. Box N.F., Duffy D.L., Chen W., Stark M., Martin N.G., Sturm R.A., et al. MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations. Am J Human Genet 69 4 (2001) 765-773